OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009

This content item was originally published on www.biopharma-reporter.com, a William Reed online publication.

By Gareth Macdonald

- Last updated on GMT

Related tags Merck kgaa

OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009
How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event.

This year, CPhI Worldwide, ICSE and P-MEC conferences in Madrid, Spain were co-hosted with a new show, BioPh, that focused on the biologics and biopharmaceutical manufacturing sector.

The event attracted a varied range of exhibitors with specialist contract manufacturing organisations (CMO) sitting side by side with dedicated big pharma units and national delegations.

in-Pharmatechnologist spoke with some with key players OctoPlus, Glycotope, Merck and SCM Pharma who shared their responses to BioPh and how well it worked in combination with the wider conferences’ focus on traditional small-molecule drug manufacturing.

Related news

Show more

Related products

show more

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Follow us

Products

View more

Webinars